Tolerance and immunological response in HIV seropositive individuals after NR100063 supplementatio

• Conditions: HIV infection; MedDRA version: 6.1Level: SOCClassification code 10021881

• Registration Number: EUCTR2005-000567-25-IT
• Lead Sponsor: MICO RESEARCH BV

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09-02
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Secondary Objective: ;Primary end point(s): ;Main Objective: